Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

TGF-β-associated extracellular matrix genes link cancer-associated fibroblasts to immune evasion and immunotherapy failure

Open access
Chakravarthy, Ankur, Khan, Lubaba, Bensler, Nathan Peter, Bose, Pinaki, De Carvalho, Daniel D. · 2018 · Nature Communications

Abstract

The extracellular matrix (ECM) is a key determinant of cancer progression and prognosis. Here we report findings from one of the largest pan-cancer analyses of ECM gene dysregulation in cancer. We define a distinct set of ECM genes upregulated in cancer (C-ECM) and linked to worse prognosis. We found that the C-ECM transcriptional programme dysregulation is correlated with the activation of TGF-β signalling in cancer-associated fibroblasts and is linked to immunosuppression in otherwise immunologically active tumours. Cancers that activate this programme carry distinct genomic profiles, such as BRAF, SMAD4 and TP53 mutations and MYC amplification. Finally, we show that this signature is a predictor of the failure of PD-1 blockade and outperforms previously-proposed biomarkers. Thus, our findings identify a distinct transcriptional pattern of ECM genes in operation across cancers that may be potentially targeted, pending preclinical validation, using TGF-β blockade to enhance responses to immune-checkpoint blockade.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-018-06654-8

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 ECM genes are significantly associated with tumorigenesis and prognosis. a Volcano plot showing fold changes for genes differentially expressed between cancer and normal samples. ECM genes are enriched in upregulated and downregulated genes. b Boxplots of C-ECM-up enrichment scores show variation across tumour types (n = 9716, see S1F for C-ECM-down genes). c Plot of Cox model coefficients by quartile for C-ECM-up and -down scores pan-cancer, error bars indicate 95% confidence intervals (n = 6128). d Unadjusted Kaplan–Meier curves showing survival by C-ECM-up-quartile., asterisks indicate statistical significance. ***p < 0.001. On the volcano plot, y axis = −log10 fold change, x axis = test statistic/fold change/Spearman’s Rho. On volcano plots, all enrichment statistics are from Fisher’s Exact Tests
Fig. 1 ECM genes are significantly associated with tumorigenesis and prognosis. a Volcano plot showing fold changes for genes differentially expressed between cancer and normal samples. ECM genes are enriched in upregulated and downregulated genes. b Boxplots of C-ECM-up enrichment scores show variation across tumour types (n = 9716, see S1F for C-ECM-down genes). c Plot of Cox model coefficients by quartile for C-ECM-up and -down scores pan-cancer, error bars indicate 95% confidence intervals (n = 6128). d Unadjusted Kaplan–Meier curves showing survival by C-ECM-up-quartile., asterisks indicate statistical significance. ***p < 0.001. On the volcano plot, y axis = −log10 fold change, x axis = test statistic/fold change/Spearman’s Rho. On volcano plots, all enrichment statistics are from Fisher’s Exact TestsCC BY · PubMed Central
Fig. 2 C-ECM transcription is associated with stroma, especially CAFs. a ABSOLUTE purity estimates are inversely correlated with C-ECM-up score, suggesting stromal origin; colours represent cancer types, number shows Spearman’s Rho (n = 8128). b Heatmaps of C-ECM-up and -down signatures projected onto microdissected epithelium and stroma from ovarian cancers. Rows show expression z-scores, samples are in columns. Annotation bars indicate tissue type. c Volcano plots show C-ECM genes (upregulated in orange, downregulated in black) differentially expressed between cancer stroma and epithelium and between cancer and normal stroma. d Volcano plots showing Spearman’s correlations between MethylCIBERSORT cell-type fractions and C-ECM scores. e Heatmap of C-ECM genes in single-cell HNSCC RNA-seq data (n = 5902). f CAFs show the highest expression of C-ECM genes relative to other cell types in single-cell HNSCC data. Numbers on scatterplots indicate Spearman’s Rho, asterisks indicate statistical significance. ***p < 0.001. On all volcano plots, y axis = −log10 fold change, x axis = test statistic/fold change/Spearman’s Rho. On volcano plots, all enrichment statistics are from Fisher’s Exact Tests
Fig. 2 C-ECM transcription is associated with stroma, especially CAFs. a ABSOLUTE purity estimates are inversely correlated with C-ECM-up score, suggesting stromal origin; colours represent cancer types, number shows Spearman’s Rho (n = 8128). b Heatmaps of C-ECM-up and -down signatures projected onto microdissected epithelium and stroma from ovarian cancers. Rows show expression z-scores, samples are in columns. Annotation bars indicate tissue type. c Volcano plots show C-ECM genes (upregulated in orange, downregulated in black) differentially expressed between cancer stroma and epithelium and between cancer and normal stroma. d Volcano plots showing Spearman’s correlations between MethylCIBERSORT cell-type fractions and C-ECM scores. e Heatmap of C-ECM genes in single-cell HNSCC RNA-seq data (n = 5902). f CAFs show the highest expression of C-ECM genes relative to other cell types in single-cell HNSCC data. Numbers on scatterplots indicate Spearman’s Rho, asterisks indicate statistical significance. ***p < 0.001. On all volcano plots, y axis = −log10 fold change, x axis = test statistic/fold change/Spearman’s Rho. On volcano plots, all enrichment statistics are from Fisher’s Exact TestsCC BY · PubMed Central
Fig. 3 E-ECM scores are associated with immunologically hot tumours and TGF-β. a C-ECM-up and down scores are significantly associated with mutational burden across cancer types but in opposite directions. b Canonical pathway analysis shows activation of inflammatory/adaptive-immune pathways. c Correlation between C-ECM-up scores and enrichment for an aggregated list of upregulated non-C-ECM TGF-beta target genes across tissues and species from MSigDB. d Volcano plot showing enrichment for C-ECM genes in TGF-β-induced transcriptional changes in immortalised normal fibroblasts. Linear model t-statistics for candidate e mutational and f copy-number alterations associated with ECM-up ssGSEA scores, adjusted for tumour type, on volcano plots. Numbers on scatterplots indicate Spearman’s Rho, asterisks indicate statistical significance. ***p < 0.001. On all volcano plots, y axis = −log10 fold change, x axis = test statistic/fold change/Spearman’s Rho. On volcano plots, all enrichment statistics are from Fisher’s Exact Tests
Fig. 3 E-ECM scores are associated with immunologically hot tumours and TGF-β. a C-ECM-up and down scores are significantly associated with mutational burden across cancer types but in opposite directions. b Canonical pathway analysis shows activation of inflammatory/adaptive-immune pathways. c Correlation between C-ECM-up scores and enrichment for an aggregated list of upregulated non-C-ECM TGF-beta target genes across tissues and species from MSigDB. d Volcano plot showing enrichment for C-ECM genes in TGF-β-induced transcriptional changes in immortalised normal fibroblasts. Linear model t-statistics for candidate e mutational and f copy-number alterations associated with ECM-up ssGSEA scores, adjusted for tumour type, on volcano plots. Numbers on scatterplots indicate Spearman’s Rho, asterisks indicate statistical significance. ***p < 0.001. On all volcano plots, y axis = −log10 fold change, x axis = test statistic/fold change/Spearman’s Rho. On volcano plots, all enrichment statistics are from Fisher’s Exact TestsCC BY · PubMed Central
Fig. 4 C-ECM scores predict failure of PD-1 blockade. a Boxplots showing distributions of C-ECM ssGSEA scores across multiple data sets of pretreatment biopsies from patients treated with PD-1 blockade. Non-responders = progressive disease (PD). p Values are from Wilcoxon’s Rank Sum Test. b Coefficients from pooled logistic regression analysis evaluating various predictors on PD-1-blockade response, error bars indicate 95% confidence intervals. c Boxplots of Cohen’s Kappa from 0.632 bootstrapping (500 resamples), showing that ECM-based models outperform other candidate biomarkers. Asterisks show q-values. d Heatmap showing C-ECM genes differentially expressed between ICB responders and nonresponders after controlling for study-specific variation. Rows show z-scores of expression (log2 CPM) and columns show samples; annotation ribbons display clinical information. e Boxplot showing C-ECM-up score distributions based on discretised categories of TGFB1 expression and the Tirosh CAF signature. All comparisons with the TGFB1 high, CAF high group were significant at FDR < 0.05 (Wilcoxon’s Rank Sum Test)
Fig. 4 C-ECM scores predict failure of PD-1 blockade. a Boxplots showing distributions of C-ECM ssGSEA scores across multiple data sets of pretreatment biopsies from patients treated with PD-1 blockade. Non-responders = progressive disease (PD). p Values are from Wilcoxon’s Rank Sum Test. b Coefficients from pooled logistic regression analysis evaluating various predictors on PD-1-blockade response, error bars indicate 95% confidence intervals. c Boxplots of Cohen’s Kappa from 0.632 bootstrapping (500 resamples), showing that ECM-based models outperform other candidate biomarkers. Asterisks show q-values. d Heatmap showing C-ECM genes differentially expressed between ICB responders and nonresponders after controlling for study-specific variation. Rows show z-scores of expression (log2 CPM) and columns show samples; annotation ribbons display clinical information. e Boxplot showing C-ECM-up score distributions based on discretised categories of TGFB1 expression and the Tirosh CAF signature. All comparisons with the TGFB1 high, CAF high group were significant at FDR < 0.05 (Wilcoxon’s Rank Sum Test)CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 48 references

Cited by

See all 733

Metadata

Authors
Chakravarthy, A., Khan, L., Bensler, N. P., Bose, P., & De Carvalho, D. D.
Affiliations
  • University Health Network (CA)
  • University of Calgary (CA)
Corresponding author
Bose, Pinaki
Venue
Nature Communications
Published
2018-11-08
Volume
9
Issue
1
Pages
4692-4692
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2899204048
Cited by
656
References
48
Citations by year
2026: 65 · 2025: 96 · 2024: 123 · 2023: 107 · 2022: 86 · 2021: 89 · 2020: 66 · 2019: 24
FWCI
16.01
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • University of Calgary
  • Cancer Research Society
  • Princess Margaret Cancer Foundation (950-231346)
  • J.P. Bickell Foundation
  • Canadian Institutes of Health Research (148430_1, 201512MSH-360794-228629, 148430, 201512MSH‐)
  • Canadian Cancer Society Research Institute
  • Natural Sciences and Engineering Research Council of Canada (489073)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Keywords
extracellular matrix genes, cancer-associated fibroblasts, TGF-beta signaling, immune evasion, immunotherapy resistance, anti-PD-1 therapy, prognostic signature, pan-cancer analysis, immunosuppression, TGF-beta blockade, BRAF mutation, SMAD4 mutation, TP53 mutation, MYC amplification, immune checkpoint molecules
MeSH terms
Cancer-Associated Fibroblasts, Extracellular Matrix, Humans, Immunotherapy, Prognosis, Transcription, Genetic, Gene Expression Regulation, Neoplastic, Transforming Growth Factor beta, Stromal Cells, Immune Evasion, Programmed Cell Death 1 Receptor, Carcinogenesis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: TGF-β-associated extracellular matrix genes link cancer-associated fibroblasts to immune evasion and immunotherapy failure. https://app.cochat.ai/papers/10.1038/s41467-018-06654-8
The paper
Chakravarthy, A., Khan, L., Bensler, N. P., Bose, P., & De Carvalho, D. D. (2018). TGF-β-associated extracellular matrix genes link cancer-associated fibroblasts to immune evasion and immunotherapy failure. Nature Communications. https://doi.org/10.1038/s41467-018-06654-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.